ASO Visual Abstract: Efficacy of Bidirectional Paclitaxel Plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single-Institution Analysis of Two Phase II Clinical Trials
本文未提供摘要,请点击“查看全文”查看完整内容。